← Leaderboards
Margaret S. Pearle
University Of Texas Sw Med Ctr/Dallas
$3,288,901
Attributed
$3,288,901
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $114.7K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$3,288,901 · 9
By mechanism
M01$2,765,759 · 7
P01$523,142 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Charles Y.c Pak$11,557,463
- Khashayar Sakhaee$14,492,169
- Christopher B Newgard$30,587,994
- Orson W Moe$15,748,560
- Naim M Maalouf$8,442,081
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectNephrolithiasisPotassiumCitratesHuman Therapy EvaluationMagnesiumCalciumLithotripsyOxalatesHypercalciuriaKidney Disorder ChemotherapyClinical TrialsPlacebosRelapse /RecurrenceDisease /Disorder EtiologyCrystallizationCalcium MetabolismUrineAffectCalcium CarbonateDisease /Disorder ClassificationIntakeDrug Screening /Evaluation
Grant awards (25)
CALCIUM-OXALATE INTERATION IN MODULATING CALCIUM OXALATE STONE FORMATION$62,263
P01 · FY2008 · DK · contact PI
CALCIUM-OXALATE INTERATION IN MODULATING CALCIUM OXALATE STONE FORMATION$64,551
P01 · FY2007 · DK · contact PI
CALCIUM-OXALATE INTERACTION IN MODULATION OF STONE FORMATION$20,141
M01 · FY2007 · RR · contact PI
CALCIUM-OXALATE INTERATION IN MODULATING CALCIUM OXALATE STONE FORMATION$57,591
P01 · FY2006 · DK · contact PI
CALCIUM-OXALATE INTERACTION IN MODULATION OF STONE FORMATION$49,594
M01 · FY2006 · RR · contact PI
CALCIUM-OXALATE INTERACTION IN MODULATION OF STONE FORMATION$58,744
M01 · FY2005 · RR
CALCIUM-OXALATE INTERATION IN MODULATING CALCIUM OXALATE STONE FORMATION$55,907
P01 · FY2005 · DK
CALCIUM-OXALATE INTERATION IN MODULATING CALCIUM OXALATE STONE FORMATION$54,283
P01 · FY2004 · DK
Calcium-Oxalate Interaction in Modulation of Stone Formation$31,229
M01 · FY2004 · RR
Management of Nephrolithiasis$221
M01 · FY2004 · RR
K-MAG FACILITATED STONE FRAGMENT DISCHARGE DURING LITHOTRIPSY$321,374
M01 · FY2002 · RR
AMBULATORY EVALUATION OF NEPHROLITHIASIS$321,374
M01 · FY2002 · RR
LONG TERM MANAGEMENT OF NEPHROLITHIASIS--CLINICAL RESPONSE AND HAZARDS$321,374
M01 · FY2002 · RR
TRIAL WITH K MAG CITRATE IN PATIENTS COMPLETING LITHOTRIPSY$321,374
M01 · FY2002 · RR
POTASSIUM-MAGNESIUM CITRATE TRIAL IN PATIENTS COMPLETING LITHOTRIPSY$228,547
P01 · FY2002 · DK
LONG TERM MANAGEMENT OF NEPHROLITHIASIS--CLINICAL RESPONSE AND HAZARDS$321,374
M01 · FY2001 · RR
TRIAL WITH K MAG CITRATE IN PATIENTS COMPLETING LITHOTRIPSY$321,374
M01 · FY2001 · RR
K-MAG FACILITATED STONE FRAGMENT DISCHARGE DURING LITHOTRIPSY$321,374
M01 · FY2001 · RR
AMBULATORY EVALUATION OF NEPHROLITHIASIS$321,374
M01 · FY2001 · RR
POTASSIUM-MAGNESIUM CITRATE TRIAL IN PATIENTS COMPLETING LITHOTRIPSY$0
P01 · FY2001 · DK
TRIAL WITH K MAG CITRATE IN PATIENTS COMPLETING LITHOTRIPSY$34,838
M01 · FY2000 · RR
AMBULATORY EVALUATION OF NEPHROLITHIASIS$0
M01 · FY2000 · RR
MANAGEMENT OF NEPHROLITHIASIS--CLINICAL RESPONSE &HAZARDS$0
M01 · FY2000 · RR
POTASSIUM-MAGNESIUM CITRATE TRIAL IN PATIENTS COMPLETING LITHOTRIPSY$0
P01 · FY2000 · DK
DISCHARGE OF STONE FRAGMENTS DURING LITHOTRIPSY BY K-MG CITRATE$0
M01 · FY2000 · RR